Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 1 2

Status

Completed 126Unknown 21Terminated 20Recruiting 18Active not recruiting 5Withdrawn 3Not yet recruiting 3Suspended 2

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5Observational 2

Sponsor

Conditions

Breast Neoplasms 705Carcinoma, Non-Small-Cell Lung 473Prostatic Neoplasms 423Neoplasms 384Multiple Myeloma 266Colorectal Neoplasms 257Lung Neoplasms 245Neoplasm Metastasis 234Melanoma 219Leukemia, Myeloid, Acute 193Ovarian Neoplasms 189Pancreatic Neoplasms 177Squamous Cell Carcinoma of Head and Neck 160Carcinoma, Renal Cell 146Recurrence 144Lymphoma 144Glioblastoma 142Lymphoma, Non-Hodgkin 136Stomach Neoplasms 128Triple Negative Breast Neoplasms 127Leukemia, Lymphocytic, Chronic, B-Cell 123Brain Neoplasms 123Carcinoma, Hepatocellular 122Head and Neck Neoplasms 116Uterine Cervical Neoplasms 115Urinary Bladder Neoplasms 115Precursor Cell Lymphoblastic Leukemia-Lymphoma 115Lymphoma, Large B-Cell, Diffuse 104Sarcoma 103Lymphoma, Follicular 100

Interventions

temsirolimus 1Vorinostat 1Sirolimus 1Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Active not recruiting × Interventional × Advanced Cancer × Clear all
NCT05408507 2026-02-09

Care Planning Framework in Advanced Cancer (ABC123)

University of Colorado, Denver

Phase NA Active not recruiting
70 enrolled

Advanced Cancer

NCT01087554 2026-01-16

Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced Cancer

M.D. Anderson Cancer Center

Phase 1 Active not recruiting
249 enrolled

Advanced Cancer

NCT05735496 2025-08-01

Clinical Trial of the TQB2102 Injection in Patients With Advanced Cancers

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 1 Active not recruiting
219 enrolled

Advanced Cancer

NCT04757155 2025-07-17

iCALM

University Health Network, Toronto

Phase NA Active not recruiting
50 enrolled

Advanced Cancer

NCT04435444 2025-07-03

Meaning-Centered Intervention for Muslim Patients Who Are Being Treated for Advanced Cancer

Memorial Sloan Kettering Cancer Center

Phase NA Active not recruiting
19 enrolled

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡